ロード中...
Scoring of PD-L1 expression intensity on pulmonary adenocarcinomas and the correlations with clinicopathological factors
INTRODUCTION: The contribution of programmed cell death ligand-1 (PD-L1) immune checkpoint molecule toward progression of non-small cell lung cancer (NSCLC) has not yet been elucidated, in part, because of lack of a standardised method to evaluate PD-L1 expression. In this study, we developed a nove...
保存先:
| 出版年: | ESMO Open |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Publishing Group
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5070269/ https://ncbi.nlm.nih.gov/pubmed/27843633 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2016-000083 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|